Colin Sperring

Resident @ColumbiaNeuro | @ColumbiaPS

[Colin Sperring @ColinSperring]

Damian’s up next!

[Damian Teasley @DamianTeasley]

So dope to see so many incredible future physicians live out their dreams and match at these incredible institutions. Super grateful and inspired by their success #Match2024

[Colin Sperring @ColinSperring]

Incredibly grateful and excited to be joining the @ColumbiaNeuro team. Thank you Dr. Jeffrey Bruce, @PCanoll , @MateiBanu, @MikeArgenziano, @ColumbiaNeuro, @CUBrainTumorLab for the incredible mentorship and support!

[Columbia Neurosurgery @ColumbiaNeuro]

Congratulations to our 2024 Matches!!! Welcome to the Columbia Neurosurgery family!

#Match2024 #MatchDay

[Journal of Neurosurgery @TheJNS]

#OnlineFirst: Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma.

https://t.co/OnvzonvMzm.

[AshuJadhav @AshuPJadhav]

No-Reflow Post-Recanalization in Acute Ischemic Stroke: Mechanisms, Measurements, and Molecular Markers | Stroke https://t.co/3w8PHaHieL

[Matei Banu @MateiBanu]

Outstanding talk by ⁦@MikeArgenziano⁩ at #AANS2023 presenting our work on #GBM and #ferroptosis demonstrating how we can target resistant cancer cells. Learning from clinical trials to advance therapy! So proud of Michael, physician scientist superstar!

[Columbia Translational Brain Tumor Laboratory @CUBrainTumorLab]

Excited that our new paper in @NatureComms is also highlighted in PNAS journal club @PCanoll @bstockwell https://t.co/6Kg0ZMiBDM

[Columbia Translational Brain Tumor Laboratory @CUBrainTumorLab]

Really happy to share our new paper published in @NatureComms, an amazing collaboration with @bstockwell lab and others, demonstrating that cysteine/methionine deprivation can sensitize glioma cells to a form of cell death called ferroptosis https://t.co/ZpAFG3ncKz

[Columbia Translational Brain Tumor Laboratory @CUBrainTumorLab]

Check out our new preprint! A study led by @MateiBanu, PGY7 @ColumbiaNeuro. We find that astrocytic-like quiescent #glioma cells are driven by distinct metabolic programs, and this treatment-resistant glioma subpop can be effectively targeted via #ferroptosis in human GBM tissue.